Clinical Trials Directory

Trials / Completed

CompletedNCT00693407

Study of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation

Activation of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation in Functional Dyspepsia Patients and Healthy Controls

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Visceral hypersensitivity as evidence of central sensory sensitization is evident in many patients with functional disorders such as functional dyspepsia (FD) and irritable bowel syndrome (IBS). We recently demonstrated both somatic hypersensitivity and abnormal endogenous pain modulation in IBS, both of which indicate central sensitization as a crucial mechanism in IBS. Endogenous pain mechanisms regulate, fine-tune and integrate sensory and homeostatic, including neuroendocrine, immune, motor and autonomic nervous system processes. Hitherto, no studies have investigated the role endogenous pain modulation in FD. Abnormal modulation could explain several of the symptom complexes associated with FD and provide a rationale for exploration of new treatments. The current study was designed to 1. investigate the gastric sensitivity in FD patients and healthy controls during gastric capsaicin stimulation 2. assess the endogenous pain inhibitory modulation system in FD patients and healthy controls during heterotopic stimulation

Conditions

Interventions

TypeNameDescription
PROCEDUREgastric capsaicin with heterotopic stimulation/ distractionThe subjects are randomized to swallow either a capsaicin 0.50mg capsule or an identical placebo capsule with 100ml of water If after 15 minutes pain scores do not reach a minimum level of 30, a further double-blinded capsule of the same content will be swallowed with 100ml of water. This is repeated to a maximum of 8 capusles until pain with VAS \>30 is reported.

Timeline

Start date
2008-09-01
Primary completion
2011-09-01
Completion
2012-09-01
First posted
2008-06-09
Last updated
2014-01-07

Locations

2 sites across 1 country: Singapore

Source: ClinicalTrials.gov record NCT00693407. Inclusion in this directory is not an endorsement.